Cystic fibrosis infection study halted early
NCT ID NCT03312075
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study aimed to find out how common non-tuberculous mycobacteria (NTM) infections are in people with cystic fibrosis in France. Researchers collected sputum and blood samples from 848 participants to test for NTM using culture and a new blood test. The study was terminated early, so results may be limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AP-HP Hôpital Cochin
Paris, 75679, France
-
AP-HP Hôpital Foch
Suresnes, 92151, France
-
CHIC Créteil
Créteil, 94000, France
-
CHR Sud Réunion
Saint-Pierre, 97410, France
-
CHRU Brest
Brest, 29200, France
-
CHU Amiens
Amiens, Amiens, 80054, France
-
CHU Bordeaux
Pessac, 33604, France
-
CHU Côte de Nacre
Caen, 14033, France
-
CHU Grenoble
Grenoble, 38043, France
-
CHU Lille
Lille, 59037, France
-
CHU Rouen
Rouen, 76031, France
-
CHU Toulouse
Toulouse, 31059, France
-
CHU Tours
Tours, 37044, France
-
Centre de Perharidy
Roscoff, 29684, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A smartphone tool may help cystic fibrosis patients survive the lung transplant waitlist
- Can a smartphone app reveal how CF treatments really work at home?
- Can a peer coach help young people take control of their chronic illness?
- Could a single antibiotic be enough for cystic fibrosis lung infections?
- Early use of powerful CF drugs may boost growth in young children
- Hands-On therapy may soothe cystic fibrosis pain without drugs